Literature DB >> 19727258

Treatment of comorbid adolescent cannabis use and major depressive disorder.

Yifrah Kaminer1, Daniel F Connor, John F Curry.   

Abstract

The comorbidity of unipolar depression with substance use disorders (SUD) in adolescents is well established and accounts for 24 to 50 percent in clinical samples. Very little empirical data exist on the treatment of dually diagnosed youth. The objective of this paper is twofold: 1) We will review the literature on SUD and unipolar depression; and 2) we will provide guidelines for a combined pharmacological and psychosocial intervention based on a clinical case example.

Entities:  

Keywords:  adolescent substance use disorders; depression; psychiatric comorbidity; treatment

Year:  2008        PMID: 19727258      PMCID: PMC2687084     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  23 in total

Review 1.  The natural history of adolescent alcohol use disorders.

Authors:  Duncan B Clark
Journal:  Addiction       Date:  2004-11       Impact factor: 6.526

2.  The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials.

Authors:  Michael Dennis; Susan H Godley; Guy Diamond; Frank M Tims; Thomas Babor; Jean Donaldson; Howard Liddle; Janet C Titus; Yifrah Kaminer; Charles Webb; Nancy Hamilton; Rod Funk
Journal:  J Subst Abuse Treat       Date:  2004-10

3.  The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers.

Authors:  K C Winters; R D Stinchfield; E Opland; C Weller; W W Latimer
Journal:  Addiction       Date:  2000-04       Impact factor: 6.526

4.  A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study.

Authors:  Deborah Deas; Carrie L. Randall; James S. Roberts; Raymond F. Anton
Journal:  Hum Psychopharmacol       Date:  2000-08       Impact factor: 1.672

5.  Cannabis withdrawal in adolescent treatment seekers.

Authors:  Ryan Vandrey; Alan J Budney; Jody L Kamon; Catherine Stanger
Journal:  Drug Alcohol Depend       Date:  2004-12-18       Impact factor: 4.492

Review 6.  Pharmacotherapy of adolescent substance use disorders: a review of the literature.

Authors:  James G Waxmonsky; Timothy E Wilens
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-10       Impact factor: 2.576

7.  A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

Authors:  Paula D Riggs; Susan K Mikulich-Gilbertson; Robert D Davies; Michelle Lohman; Constance Klein; Shannon K Stover
Journal:  Arch Pediatr Adolesc Med       Date:  2007-11

8.  Psychotherapies for adolescent substance abusers: a pilot study.

Authors:  Y Kaminer; J A Burleson; C Blitz; J Sussman; B J Rounsaville
Journal:  J Nerv Ment Dis       Date:  1998-11       Impact factor: 2.254

9.  Screening and assessing adolescent substance use disorders in clinical populations.

Authors:  Ken C Winters; Yifrah Kaminer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-07       Impact factor: 8.829

10.  Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program.

Authors:  Aaron M White; Jonathan D Jordan; Kristin M Schroeder; Shawn K Acheson; Becky D Georgi; Gary Sauls; Roxanne R Ellington; H Scott Swartzwelder
Journal:  Subst Abus       Date:  2004-03       Impact factor: 3.716

View more
  7 in total

1.  Emerging trends and innovations in the identification and management of drug use among adolescents and young adults.

Authors:  Sarah Lord; Lisa Marsch
Journal:  Adolesc Med State Art Rev       Date:  2011-12

Review 2.  Multidimensional family therapy: addressing co-occurring substance abuse and other problems among adolescents with comprehensive family-based treatment.

Authors:  Cynthia L Rowe
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-07

3.  Reductions in anxiety and depression symptoms in youth receiving substance use treatment.

Authors:  Viviana E Horigian; Carl F Weems; Michael S Robbins; Daniel J Feaster; Jessica Ucha; Michael Miller; Robert Werstlein
Journal:  Am J Addict       Date:  2013 Jul-Aug

4.  The concurrent validity of the Problem Oriented Screening Instrument for Teenagers (POSIT) substance use/abuse subscale in adolescent patients in an urban federally qualified health center.

Authors:  Sharon M Kelly; Kevin E O'Grady; Jan Gryczynski; Shannon Gwin Mitchell; Arethusa Kirk; Robert P Schwartz
Journal:  Subst Abus       Date:  2017-07-07       Impact factor: 3.716

5.  A preliminary examination of how serotonergic polymorphisms influence brain response following an adolescent cannabis intervention.

Authors:  Sarah W Feldstein Ewing; Hilary K Mead; Uma Yezhuvath; Sam Dewitt; Kent E Hutchison; Francesca M Filbey
Journal:  Psychiatry Res       Date:  2012-11-30       Impact factor: 3.222

Review 6.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

7.  Multiplicative Effects of Social and Psychological Risk Factors on College Students' Suicidal Behaviors.

Authors:  Shervin Assari
Journal:  Brain Sci       Date:  2018-05-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.